Nymox Pharmaceutical Corporation
NYMXF
$0.1364
$0.026424.00%
OTC PK
| 09/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -46.05% | -95.01% | -97.19% | -97.19% | -96.76% |
| Total Receivables | 228.57% | 10.00% | -30.00% | -30.00% | 11.11% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -95.76% | 0.00% | 302.22% | 302.22% | 0.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,814.29% | 1,785.71% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -4.74% | -57.10% | -77.53% | -77.53% | -94.89% |
|
|
|||||
| Total Current Assets | -4.74% | -57.10% | -77.53% | -77.53% | -94.89% |
| Net Property, Plant & Equipment | -93.33% | -98.81% | -93.48% | -93.48% | -80.28% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -6.73% | -61.42% | -78.70% | -78.70% | -93.94% |
|
|
|||||
| Total Accounts Payable | 68.52% | 78.14% | 19.57% | 19.57% | 19.66% |
| Total Accrued Expenses | -- | -88.61% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -94.91% | -94.91% | -76.29% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 169.16% | 80.35% | 9.08% | 9.08% | 43.74% |
|
|
|||||
| Total Current Liabilities | 169.16% | 80.35% | 9.08% | 9.08% | 43.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 169.16% | 80.35% | 8.57% | 8.57% | 40.41% |
|
|
|||||
| Common Stock & APIC | 0.41% | 1.48% | 0.81% | 0.81% | -0.19% |
| Retained Earnings | -4.41% | -4.44% | -2.46% | -2.46% | -2.71% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -231.02% | -558.30% | -346.05% | -346.05% | -228.90% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -231.02% | -558.30% | -346.05% | -346.05% | -228.90% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -231.02% | -558.30% | -346.05% | -346.05% | -228.90% |
|
|
|||||